Skip to main content
Premium Trial:

Request an Annual Quote

Mary Jane Cunningham, William Rutter, Ed Umali, David Haen, Carolyn French, Thomas Goralski, Michael Knable

Premium

Houston Advanced Research Center has appointed Mary Jane Cunningham as associate director of life sciences & health.

Mary Jane Cunningham comes to HARC from Molecular Mining, where she was director of discoveries. Before her stint at Molecular Mining, Cunningham, was director of pharmacogenomics at now-defunct microarray firm Genometrix, of the Woodlands, Texas.


NuGen Technologies has named Chiron co-founder William Rutter director. The appointment follows Rutter’s participation in a $7.5 million Series C round of venture-capital financing that NuGen secured four weeks ago. The company, which makes nucleic acid and protein-amplification and -detection systems, said the proceeds of the financing would be used to further develop its infrastructure and its products.


CytRx, of Los Angeles, has hired three new senior executives, all from The Kriegsman Group: Ed Umali will become director of operations; David Haen will become director of business development; and Carolyn French will become director of communications.

French’s position at CytRx is on a full-time basis, while Umali and Haen are expected to continue to provide certain services to The Kriegsman Group on a limited basis.


Expression Analysis, a microarray genetics-testing and -analysis company, has named Thomas Goralski laboratory director. Goralski will be responsible for the firm’s lab operations, including improving efficiency, lowering costs, and developing and managing staff. Goralski comes to Expression Analysis from Perlegen Sciences, where he was director of production.


Michael Knable has been named to the board of Psychiatric Genomics, the firm said today. He is executive director of Stanley Medical Research Institute.

 

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.